Editas Medicine
EDIT
#8456
Rank
โ‚ฌ0.26 B
Marketcap
1,70ย โ‚ฌ
Share price
-13.82%
Change (1 day)
-23.55%
Change (1 year)

EPS for Editas Medicine (EDIT)

EPS in 2026 (TTM): -0,65ย โ‚ฌ

According to Editas Medicine 's latest financial reports the company's current EPS (TTM) is -0,68ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -1,72ย โ‚ฌ an increase over its 2024 EPS that were of -2,62ย โ‚ฌ.

EPS history for Editas Medicine from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-0,65ย โ‚ฌ-62.38%
2025-1,72ย โ‚ฌ-34.37%
2024-2,62ย โ‚ฌ40.49%
2023-1,86ย โ‚ฌ-36.14%
2022-2,92ย โ‚ฌ12.63%
2021-2,59ย โ‚ฌ42.91%
2020-1,81ย โ‚ฌ-25.86%
2019-2,44ย โ‚ฌ15.45%
2018-2,12ย โ‚ฌ-21.81%
2017-2,71ย โ‚ฌ-1.65%
2016-2,75ย โ‚ฌ-29.19%
2015-3,89ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Organovo
ONVO
-10,46ย โ‚ฌ 1,436.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-6,45ย โ‚ฌ 846.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-1,38ย โ‚ฌ 102.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
-0,96ย โ‚ฌ 41.33% Jersey